# US 2023/0053864 A1 · Methods for Identifying Modulators of G Protein-Coupled Receptors

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0053864 A1
- Document ID: US20230053864A1
- Status: Published application
- Kind: A1
- Application number: 17/785,524
- Filed: 2020-12-16
- Published: 2023-02-23
- Earliest claimed: 2019-12-17
- Assignees: University of Miami
- Applicants: University of Miami
- Inventors: Daniel Isom; William Morgan; Nicholas Kapolka; Geoffrey Taghon; Jacob Rowe
- Web page: https://patentgrep.com/patent/US20230053864A1

## CPC

- G01N 33/6872: {Intracellular protein regulatory factors and their receptors, e.g. including ion channels}
- C07K 14/4722: {G-proteins}
- C07K 14/705: Receptors; Cell surface antigens; Cell surface determinants {(tumour specific antigens C07K14/4748)}
- C12N 15/905: {in yeast}
- C12N 15/111: {General methods applicable to biologically active non-coding nucleic acids}
- C12N 2310/20: involving clustered regularly interspaced short palindromic repeats [CRISPR]
- C12N 2320/12: in functional genomics, i.e. for the determination of gene function
- G01N 33/502: {for testing non-proliferative effects}
- G01N 2500/04: Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
- G01N 2500/10: involving cells
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The disclosure relates to a plurality of cells, compositions and methods for identifying modulators of a target protein. The cells, compositions and methods comprise a (i) a target domain gene (ii) an intracellular chimeric G-protein alpha subunit comprising an endogenous G-protein alpha subunit with a humanized C-terminus; and (iii) an inducible reporter, wherein the expression of the reporter is dependent on the activation of the target domain encoded by target domain gene, and wherein the target domain gene comprises a barcode. The disclosure further relates to a host cell comprising a plurality of exogenous landing pads integrated in the host cell's genome, wherein each exogenous landing pad is integrated at a safe harbor genome loci in the host cell's genome.

## Claims

### Claim 1

A plurality of cells, wherein each cell comprises (i) one or more of a target domain gene that specifically binds to a binding partner (ii) one or more of an intracellular chimeric G-protein alpha subunit comprising an endogenous G-protein alpha subunit with a humanized C-terminus; and (iii) one or more of an inducible reporter, wherein the expression of the reporter is dependent on the activation of the target domain encoded by the target domain gene, and wherein the target domain gene comprises a barcode.

### Claim 2 (depends on 1)

The plurality of cells of claim 1, wherein the one or more of target domain is a membrane channel, a symporter transporter, an antiporter transporter, an ATPase, an enzyme or a receptor.

### Claim 3 (depends on 2)

The plurality of cells of claim 2, wherein the receptor is a G-protein coupled receptor (GPCR).

### Claim 4 (depends on 1)

The plurality of cells of claim 1, wherein the one or more of inducible reporter is a transcriptional reporter.

### Claim 5 (depends on 1)

The plurality of cells of claim 1, wherein the transcriptional reporter is mTurquoise2.

### Claim 6 (depends on 1)

The plurality of cells of claim 1, wherein the cells are yeast cells.

### Claim 7 (depends on 6)

The plurality of cells of claim 6, where the yeast cells are Saccharomyces cervisiae.

### Claim 8 (depends on 6)

The plurality of cells of claim 6, wherein the yeast cells lack an endogenous GPCR.

### Claim 9 (depends on 1)

A method for identifying a compound capable of modulating the activity of a target domain, comprising:
(a) contacting the plurality of cells of claim 1 with a compound;
(b) determining the activity of the target domain by detecting the reporter; wherein detection of the reporter in the cell indicates that the compound interacts with the target domain.

### Claim 10 (depends on 9)

The method of claim 9, wherein the target domain is a membrane channel, a symporter transporter, an antiporter transporter, an ATPase, an enzyme or a receptor.

### Claim 11 (depends on 10)

The method of claim 10, wherein the receptor is a G-protein coupled receptor (GPCR).

### Claim 12 (depends on 10)

The method of claim 10, wherein the compound is a metabolite, lead compound, drug, natural product, or other experimental small molecule, lipid, peptide, or protein.

### Claim 13

A yeast cell comprising a plurality of landing pads integrated in the yeast cell's genome, wherein each exogenous landing pad is integrated at a safe harbor genome loci in the yeast cell's genome.

### Claim 14 (depends on 13)

The yeast cell of claim 13, wherein the yeast cell comprises between 1 to 4 exogenous landing pads.

### Claim 15 (depends on 14)

The yeast cell of claim 14, wherein the yeast cell comprises 4 exogenous landing pads.

### Claim 16 (depends on 13)

The yeast cell of claim 13, where the yeast cell is Saccharomyces cervisiae.

### Claim 17 (depends on 13)

The yeast cell of claim 13, wherein the plurality of exogenous landing pads are integrated at loci X-2, X-3, XI-2, and/or XII-5 of the yeast cell's genome.

### Claim 18 (depends on 13)

The yeast cell of claim 13, wherein the plurality of exogenous landing pads comprise a unique targeting sequence.

### Claim 19 (depends on 13)

The yeast cell of claim 13, wherein the plurality of exogenous landing pads comprise a unique targeting sequence, a PAM site, and buffer DNA.

### Claim 20 (depends on 13)

The yeast cell of claim 13, wherein the plurality of exogenous landing pads are integrated sequentially.

### Claim 21 (depends on 20)

The yeast cell of claim 20, wherein the landing pads are integrated sequentially in the following order: X-2, XII-5, X-3, and XI-2.
